日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Modulation of the clonal burden in patients with lower-risk myelodysplastic neoplasms treated with imetelstat

伊美替司他治疗低危骨髓增生异常综合征患者的克隆负荷调节

Santini, Valeria; Zeidan, Amer M; Van Eygen, Koen; Fenaux, Pierre; Germing, Ulrich; Madanat, Yazan F; Raza, Azra; Savona, Michael R; Sekeres, Mikkael A; Thépot, Sylvain; Raddi, Marco G; Boyer, Thomas; Sun, Libo; Wan, Ying; Berry, Tymara; Xia, Qi; Huang, Fei; Dougherty, Souria; Navada, Shyamala; Feller, Faye; Komrokji, Rami S; Platzbecker, Uwe

Clinical outcomes and safety in patients with lower-risk myelodysplastic syndromes treated with imetelstat: Substudy of the phase 3 IMerge trial

伊美替司他治疗低危骨髓增生异常综合征患者的临床结果和安全性:3期IMerge试验的子研究

Komrokji, Rami S; Santini, Valeria; Platzbecker, Uwe; Van Eygen, Koen; Díez-Campelo, María; de Paz, Raquel; Santillana, Guillermo Sanz; Thépot, Sylvain; Kaźmierczak, Maciej; Oliva, Esther Natalie; Sekeres, Mikkael A; Fenaux, Pierre; Madanat, Yazan F; Savona, Michael R; Riggs, Jennifer; Shah, Sheetal; Lennox, Ashley L; Xia, Qi; Sun, Libo; Berry, Tymara; Zeidan, Amer M

Leveraging Digital Technology and Artificial Intelligence to Describe the Real-World Belgian Chronic Lymphocytic Leukemia Patient Population: The BE-CLLEAR Study

利用数字技术和人工智能描述比利时慢性淋巴细胞白血病患者群体的真实情况:BE-CLLEAR 研究

Vanderkerken, Matthias; Van Eygen, Koen; Galle, Veerle; Verbiest, Annelies; Janssens, Ann; Masuy, Imke; Theys, Kristof; Cuppens, Tine; Muylle, Katoo; De Becker, Ann

Cabotegravir and rilpivirine for treatment of HIV infection in Africa: week 96 results from the phase 3b randomized, open-label, noninferiority CARES trial

卡博特韦和利匹韦林治疗非洲 HIV 感染:3b 期随机、开放标签、非劣效性 CARES 试验第 96 周结果

Kityo, Cissy; Mambule, Ivan K; Musaazi, Joseph; Sokhela, Simiso; Mugerwa, Henry; Yawe, Ibrahim; Cresswell, Fiona; Siika, Abraham; Kosgei, Josphat; Shah, Reena; Naidoo, Logashvari; Opiyo, Kimton; Otike, Caroline; Möller, Karlien; Okwero, Max; Wambui, Charity; Van Eygen, Veerle; Mohammed, Perry; Addo Boateng, Fafa; Paton, Nicholas I

Daily Mosnodenvir as Dengue Prophylaxis in a Controlled Human Infection Model

在受控的人体感染模型中,每日服用莫斯诺登韦预防登革热

Durbin, Anna P; Van Wesenbeeck, Liesbeth; Pierce, Kristen K; Herrera-Taracena, Guillermo; Ebone, Laura; Buelens, Annemie; Lutton, Patricia; Sabundayo, Beulah P; Van Eygen, Veerle; De Clerck, Kim; Fetter, Isabel; Voge, Natalia V; Fang, Xi; Goeyvaerts, Nele; Vandendijck, Yannick; Mayfield, Jeffrey; Lenz, Oliver; De Meyer, Sandra; Kakuda, Thomas N; He, Huili; Amaro-Carambot, Emérito; Akli, Ruxandra Draghia; Carmolli, Marya; De Marez, Tine; Whitehead, Stephen S; Van Loock, Marnix; Rasschaert, Freya

The 96-week outcomes and pharmacokinetics of long-acting cabotegravir plus rilpivirine in South Africans

南非人接受长效卡博特韦加利匹韦林治疗96周的疗效和药代动力学研究

Mngqibisa, Rosie; Singh, Yashna; Orrell, Catherine; Lombaard, Johan; Griffith, Sandy; Harrington, Conn; D'Amico, Ronald; Spreen, William; St Clair, Marty; Latham, Christine; Garside, Louise; Van Solingen-Ristea, Rodica; Van Eygen, Veerle; Boateng, Fafa Addo; Crauwels, Herta; Eneh, Prosperity; Eshun-Wilsonova, Ingrid

Efficacy and Safety of Long-acting Injectable Cabotegravir and Rilpivirine in Improving HIV-1 Control in sub-Saharan Africa: Protocol for a Phase 3b Open-Label Randomized Controlled Trial (IMPALA)

长效注射用卡博特韦和利匹韦林在改善撒哈拉以南非洲 HIV-1 控制方面的疗效和安全性:一项 3b 期开放标签随机对照试验方案 (IMPALA)

Tumusiime, Victoria Babirye; Ruzagira, Eugene; Norcross, Claire; Eshun-Wilsonova, Ingrid; Kitonsa, Jonathan; Bahemuka, Ubaldo Mushabe; Grint, Daniel; Kimbugwe, Geofrey; Kakande, Ayoub; Lawrence, David S; Mwendia, Fridah; Van Solingen, Rodica; Van Eygen, Veerle; Addo Boateng, Fafa; Cresswell, Fiona

Pharmacokinetics, Safety and Antiviral Activity of Rilpivirine in Antiretroviral-naïve Children With HIV ≥6 to <12 Years Old: Week 48 and Final Analysis of Cohort 2 From the Open-label, Phase 2 PAINT Study

利匹韦林在既往未接受过抗逆转录病毒治疗的 HIV 感染儿童(≥6 岁至 <12 岁)中的药代动力学、安全性和抗病毒活性:开放标签 II 期 PAINT 研究第 2 组队列第 48 周和最终分析

Lombaard, Johan; Moolasart, Visal; Lutaakome, Joseph; Van Solingen-Ristea, Rodica; Van Eygen, Veerle; Van Hemelryck, Sandy; Foulkes, Sharne; Natukunda, Eva; Kurosawa, Ken; Shibuya, Minaka; Vanveggel, Simon; Van Landuyt, Erika; Ssali, Francis

Safety of combined long-acting injectable cabotegravir and long-acting injectable rilpivirine in virologically suppressed adolescents with HIV (IMPAACT 2017/MOCHA): a phase 1/2, multicentre, open-label, non-comparative, dose-finding study

在病毒学抑制的 HIV 感染青少年中,联合使用长效注射卡博特韦和长效注射利匹韦林的安全性(IMPAACT 2017/MOCHA):一项 1/2 期、多中心、开放标签、非对照、剂量探索性研究

Moore, Carolyn Bolton; Baltrusaitis, Kristin; Best, Brookie M; Moye, John H; Townley, Ellen; Violari, Avy; Heckman, Barbara; Buisson, Sarah; Van Solingen-Ristea, Rodica M; Capparelli, Edmund V; Marzinke, Mark A; Lowenthal, Elizabeth D; Ward, Shawn; Krotje, Chelsea; Milligan, Ryan; Agwu, Allison L; Huang, Jenny; Cheung, S Y Amy; McCoig, Cynthia; Yin, Dwight E; Roberts, Gilly; Crauwels, Herta; Van Eygen, Veerle; Zabih, Sara; Masheto, Gaerolwe; Ounchanum, Pradthana; Aurpibul, Linda; Korutaro, Violet; Gaur, Aditya H

Real-life data of luspatercept in lower-risk myelodysplastic syndromes advocate new research objectives

鲁斯帕西普治疗低危骨髓增生异常综合征的真实世界数据提示需要制定新的研究目标

Heyrman, Bert; Meers, Stef; Sid, Sélim; Put, Natalie; Theunissen, Koen; Van Eygen, Koen; De Beule, Nathan; Clauwaert, Maxime; Maes, Helena; Salembier, Alexander; Lemmens, Jan; Velde, Ann Van De; Selleslag, Dominik; Bouziotis, Jason; De Becker, Ann; Anguille, Sébastien